Found: 74
Select item for more details and to access through your institution.
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1831, doi. 10.3390/biomedicines12081831
- By:
- Publication type:
- Article
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 217, doi. 10.1007/s10637-017-0435-2
- By:
- Publication type:
- Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
- By:
- Publication type:
- Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 635, doi. 10.1513/AnnalsATS.202311-941OC
- By:
- Publication type:
- Article
Unilateral Upper Lung Field Pulmonary Fibrosis Radiologically Consistent with Pleuroparenchymal Fibroelastosis after Thoracotomy: A New Disease Entity Related to Thoracotomy.
- Published in:
- Respiration, 2017, v. 94, n. 5, p. 431, doi. 10.1159/000479331
- By:
- Publication type:
- Article
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 10, p. 1679, doi. 10.1038/s41416-024-02615-9
- By:
- Publication type:
- Article
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
- By:
- Publication type:
- Article
Correction to: Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 12, p. 1585, doi. 10.1007/s10147-023-02414-x
- By:
- Publication type:
- Article
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 640, doi. 10.1634/theoncologist.2017-0059
- By:
- Publication type:
- Article
Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.
- Published in:
- Oncologist, 2012, v. 17, n. 6, p. 863, doi. 10.1634/theoncologist.2011-0426
- By:
- Publication type:
- Article
A case of severe arthralgia with malignant mesothelioma-associated hypertrophic osteoarthropathy.
- Published in:
- Clinical Case Reports, 2016, v. 4, n. 11, p. 1057, doi. 10.1002/ccr3.709
- By:
- Publication type:
- Article
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
- By:
- Publication type:
- Article
Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 371, doi. 10.1016/j.cllc.2020.11.004
- By:
- Publication type:
- Article
Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
- By:
- Publication type:
- Article
Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 626, doi. 10.1002/cam4.3641
- By:
- Publication type:
- Article
Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 391, doi. 10.3390/diagnostics11030391
- By:
- Publication type:
- Article
Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with "adenocarcinoma" and "non‐small cell carcinoma favor adenocarcinoma".
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 6, p. 458, doi. 10.1111/1759-7714.15214
- By:
- Publication type:
- Article
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 22, p. 3217, doi. 10.1111/1759-7714.14685
- By:
- Publication type:
- Article
A case of lung adenocarcinoma with a novel CD74‐ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 18, p. 2504, doi. 10.1111/1759-7714.14093
- By:
- Publication type:
- Article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 1940, doi. 10.1002/cncr.32749
- By:
- Publication type:
- Article
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung.
- Published in:
- Journal of Pathology, 2003, v. 200, n. 1, p. 82, doi. 10.1002/path.1321
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923431
- By:
- Publication type:
- Article
A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923431
- By:
- Publication type:
- Article
Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7162
- By:
- Publication type:
- Article
Erratum to: Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy.
- Published in:
- Medical Oncology, 2014, v. 31, n. 10, p. 1, doi. 10.1007/s12032-014-0228-9
- By:
- Publication type:
- Article
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Diffuse Alveolar Hemorrhage as a Fatal Adverse Effect of Bevacizumab: An Autopsy Case.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 5, p. 497, doi. 10.1093/jjco/hyu023
- By:
- Publication type:
- Article
Phase I Study of Cisplatin Analogue Nedaplatin, Paclitaxel, and Thoracic Radiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 3, p. 175, doi. 10.1093/jjco/hym008
- By:
- Publication type:
- Article
Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 194, doi. 10.1111/1759-7714.13743
- By:
- Publication type:
- Article
Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3576, doi. 10.1111/1759-7714.13703
- By:
- Publication type:
- Article
Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan.
- Published in:
- Lung Cancer: Targets & Therapy, 2017, v. 8, p. 191, doi. 10.2147/LCTT.S140491
- By:
- Publication type:
- Article
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 153, doi. 10.1093/jjco/hyac159
- By:
- Publication type:
- Article
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072
- By:
- Publication type:
- Article
Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 909, doi. 10.1093/jjco/hyaa067
- By:
- Publication type:
- Article